Patents
Patents for C07D 237 - Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings (8,468)
07/2007
07/11/2007CN1325489C Substituted alkylaminopyridazinone derivatives, process for the preparation thereof and pharmaceutical composition containing the same
07/10/2007US7241889 2-Amino-5-formyl-substituted, e.g., 2-[p-(cyclopropylaminocarbonyl)phenyl]-5-formyl-8-isopentyl--7-methyl-5,6,7,8-tetrahydropteridine; antiproliferative agents
07/10/2007US7241721 carboxamide derivatives as active ingredients which have microbiocidal activity, in particular fungicidal activity
07/05/2007WO2007058392A9 Heterocyclic compound and medicinal application thereof
07/05/2007US20070155671 e.g. N-[2-chloro-4-[[[(3-hydroxyphenyl)methyl]amino]carbonyl]benzoyl]-3-(phenylmethyl)amino-L-alanine; intercellular adhesion molecules blocking agent; antiinflammatory; reperfusion injury following acute myocardial infarction
07/05/2007CA2631777A1 Substituted isoquinoline-1,3(2h,4h)-diones, 1-thioxo-1,4-dihydro-2h-isoquinoline-3-ones and 1,4-dihydro-3(2h)-isoquinolones and use thereof as kinase inhibitor
07/04/2007EP1802585A1 4-substituted 4,6-dialkoxy-cinnoline derivatives as phospodiesterase 10 inhibitors for the treatment of psychiatric or neurological syndroms
07/04/2007CN1324014C Pyridazin-3(2h)-one derivatives as PDE4 inhibitors
07/03/2007US7238717 S,N-diarylsulfonamide derivatives; treating inflammatory diseases such as Celiac's disease, Crohn's disease or colitis.
07/03/2007US7238693 Gastrointestinal disorders; central nervous system disorders; cardiovascular disorders
06/2007
06/28/2007WO2007073283A1 Substituted cinnoline derivatives as gabaa-receptor modulators and method for their synthesis
06/28/2007WO2007071358A1 Nicotinic acid derivatives as modulators of metabotropic glutamate receptors
06/28/2007WO2007071311A1 2 -phenylethylamino derivatives as calcium and/or sodium channel modulators
06/28/2007WO2007048065A3 Pyrimidinones as casein kinase ii (ck2) modulators
06/28/2007WO2007044085A3 Heteroaryl compounds and their uses as therapeutic agents
06/28/2007US20070149531 Antiviral agents
06/28/2007US20070149530 Antiviral agents
06/28/2007CA2634305A1 Substituted cinnoline derivatives as gabaa-receptor modulators and method for their synthesis
06/28/2007CA2629065A1 2 -phenylethylamino derivatives as calcium and/or sodium channel modulators
06/28/2007CA2627630A1 Nicotinic acid derivatives as modulators of metabotropic glutamate receptors
06/27/2007EP1799651A2 Small molecule modulators of cytokine activity
06/27/2007EP1583967B1 Method for inhibiting the replication of herpes viruses
06/27/2007CN1989110A Theramutein调节剂 Theramutein moderator
06/27/2007CN1989100A Therapeutic compounds
06/27/2007CN1988907A Dual small molecule inhibitors of cancer and angiogenesis
06/21/2007WO2007030567A3 Pparactive compounds
06/21/2007WO2007022380A3 Bis-aryl amide compounds and methods of use
06/21/2007US20070142393 Sulfonyl-derivatives as novel inhibitors of histone deacetylase
06/21/2007US20070142382 4-Amino-8-(2-fluoro-6-methoxy-phenyl)-N-propylcinnoline-3-carboxamide and salts; for treatment or prophylaxis of anxiety disorders, cognitive disorders, and/or mood disorders.
06/21/2007US20070142381 Calcium receptor modulating agents
06/21/2007US20070142329 2-Chloro-N-[2-(2-chloro-phenyl)-ethyl]-5-(6-oxo-1,6-dihydro-pyrazin-3-yl)benzamide, for example; useful in the treatment of IL-1 mediated disorders, including inflammatory diseases such as osteoarthritis and rheumatoid arthritis, allergies, asthma, COPD, cancer
06/21/2007US20070142328 Compounds and Uses Thereof
06/20/2007EP1796669A2 Aminopiperidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
06/19/2007US7232821 (2-((2-alkoxy)-phenyl) -cyclopent-1enyl) aromatic carbo and heterocyclic acid and derivatives
06/19/2007US7232792 3-heterocyclyl-substituted benzoyl derivatives
06/14/2007WO2007066615A1 Novel activator of nuclear orphan receptor and use thereof
06/14/2007WO2007065518A1 Pyridiazinone derivatives for tumour treatment
06/14/2007WO2007030582A3 Acyclic ikur inhibitors
06/14/2007US20070135634 Fluorinating agent and method for producing fluorine-containing compound using the same
06/14/2007US20070134161 Methods of determining beta-iii tubulin expression
06/14/2007CA2632217A1 Pyridiazinone derivatives for the treatment of tumours
06/13/2007CN1978439A Star-shaped oligothiophene-arylene derivatives and organic thin film transistors using the same
06/12/2007US7230139 Diterpenoid compounds, compositions thereof and their use as anti-cancer or anti-fungal agents
06/12/2007US7230031 Thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof
06/12/2007US7229993 Aryl substituted pyrimidines and the use thereof
06/07/2007WO2007063934A1 Alicyclic heterocyclic compound
06/07/2007WO2007037898A3 Theramutein modulators
06/07/2007US20070129546 Chlorinating 1-2H-phthalazinone with POCl3; precipitating with a mineral acid or a strong organic acid in the presence of a 1st solvent to recover 1-chlorophthalazine salt; reacting the salt with hydrazine hydrate and precipitating the base in 2nd solvent; and forming the chloride salt in a 3rd solvent
06/07/2007US20070129373 Phthalazinone-piperidino-derivatives as PDE4 inhibitors
06/07/2007US20070128680 Reacting a dicarboxylic acid with a water soluble hydrazine in the presence of a Lewis acid (NbCl5); forming phthalazinediones such as luminol
06/06/2007EP1791816A1 Iodine-phenyl-substituted cyclic cetoenols
06/06/2007DE102005057924A1 Pyridazinonderivate Pyridazinone derivatives
06/06/2007CN1976904A Pyridazin-3(2H)-one derivatives and their use as PDE4 inhibitors
06/06/2007CN1976585A Substituted pyridazine carboxamides and derivatives thereof
06/06/2007CN1974546A Diphenol derivative containing aromatic schiff base and ether band structure and its prepn and application
06/05/2007CA2269561C Naphthalene derivative and liquid crystal composition comprising the same
05/2007
05/31/2007WO2005099688A3 Cyclic compounds
05/31/2007US20070123705 Alkylation; serotonin receptor antagonists; depression, obsessive compulsive disorders, panic disorder, generalized anxiety disorder, social anxiety, sexual dysfunction, bulimia, obesity, addictive disorder
05/30/2007EP1789396A1 Substituted phenylacetamides and their use as glucokinase activators
05/30/2007EP1263723B1 Ningalin b analogs employable for reversing multidrug resistance
05/30/2007EP0914605B1 Molecular model for vla-4 inhibitors
05/29/2007US7223868 Heteroaromatic glucokinase activators
05/29/2007US7223758 Such as (3S)-2-[3-[(phenylacetyl)amino]-1-oxopropyl]-N-[cyano(3-phenoxyphenyl)methyl]hexahydro-3-pyridazinecarboxamide; for treatment of osteoporosis, hypercalcaemia, osteoporosis, gingival disease, arthritis, Paget's disease, and bone cancer
05/24/2007WO2007058392A1 Heterocyclic compound and medicinal application thereof
05/23/2007EP1786823A1 Alkylidene tetrahydronaphthalene derivatives, method for their production and their use as anti-inflammatory agents
05/23/2007EP0948335B1 Methods of treating or preventing cardiac arrhythmia
05/22/2007US7220858 Synthesis of hydrazine and chlorinated derivatives of bicyclic pyridazines
05/22/2007US7220857 Azo dye compound
05/22/2007CA2368347C Glucokinase activators
05/22/2007CA2157146C Heterocyclyl-benzoylguanidines
05/18/2007WO2007002313A3 Phenylglycinamide and pyridylglycinamide derivatives useful as anticoagulants
05/16/2007CN1964953A Novel 3-phenyltetrahydrocinnolin-5-ol derivative and medicinal use thereof
05/16/2007CN1964952A Pyridazin-3(2h)-one derivatives and their use as PDE4 inhibitors
05/16/2007CN1962644A PI3K enzyme inhibitor-5-(3-amino-benzene) methyl nicotinate analog
05/16/2007CN1962642A Trifluoromethylphenylpyridazine derivative and its preparation method
05/15/2007US7217844 Useful for inhibiting the growth of a cancer cell or neoplastic cell, or for inducing apoptosis in a cancer or neoplastic cell; reduced side effects
05/15/2007US7217728 For therapy of reperfusion injury
05/09/2007EP1781621A1 Pyridazin-3(2h)-one derivatives and their use as pde4 inhibitors
05/09/2007EP1781620A1 Novel beta agonists, method for producing the same and their use as drugs
05/09/2007EP1781614A1 Compounds which potentiate glutamate receptor and uses thereof in medicine
05/09/2007EP1254907B1 Pyrrolopyridazine compound
05/09/2007CN1958577A Method for preparing 3, 4, 6 triclopyridazine in high purity, and application of production
05/03/2007WO2007048802A1 (hetero)aryl compounds with mch antagonistic activity and medicaments comprising these compounds
05/03/2007WO2007021858A3 Methods of making radiolabeled tracers and precursors thereof
05/03/2007US20070099921 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
05/03/2007US20070099895 1-amino-phthalazine derivatives, the preparation and the therapeutic use thereof
05/03/2007CA2626747A1 (hetero)aryl compounds with mch antagonistic activity and medicaments comprising these compounds
05/02/2007EP1780196A2 Pyridine derivatives for use as vanilloid receptor ligands
05/02/2007EP1778640A1 Trifluoromethyl substituted benzamides as kinase inhibitors
05/02/2007EP0946183B1 Use of pyridazinone or phosphine oxide compounds to treat or prevent cardiac arrhythmia
05/01/2007US7211577 Water-soluble phenylpyridazine derivative and medicine containing the same
05/01/2007CA2305458C Nonsteroidal (hetero) cyclically-substituted acylanilides with mixed gestagenic and androgenic activity
04/2007
04/26/2007WO2007045861A1 Cinnoline compounds as inhibitors of phosphodiesterase type iv (pde4)
04/26/2007CA2626789A1 Pyrimidinones as casein kinase ii (ck2) modulators
04/25/2007CN1953972A 1-amino-phthalazine derivatives, the preparation and the therapeutic use thereof
04/24/2007USRE39590 3-(4-chloro-6-fluoro-3-methoxy-2-nitrophenyl)-6-trifluoromethyl-2,4(1H, 3H)-pyrimidinedione; useful for general or pre-emergent or post-emergent control of undesired plant species and defoliants at very low concentrations
04/24/2007CA2075173C Compounds and methods for inhibition of hiv and related viruses
04/19/2007WO2007044085A2 Heteroaryl compounds and their uses as therapeutic agents
04/18/2007EP1775290A1 Pyridazine compound and use thereof
04/18/2007EP1773784A2 Anti-inflammatory medicaments
1 ... 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 ... 85